Drug
Biricodar Dicitrate
Biricodar Dicitrate: highest development phase Phase 2, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| biricodar dicitrate NCT00003847 | Phase 2 | Lung Cancer |
Latest
No recent events.
Follow Biricodar Dicitrate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.